A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but don’t address the root problem.
Categories
Recent Posts
- Clinical Research Alert: Phase 1b Study of SRD-001 in Adults with DMD-Related Cardiomyopathy
- Holiday Gift Wrapping Made Easier: Accessible Tips & Tricks
- Planning a ‘Krank’ Christmas and getaway with accessibility in mind
- Protected: Honoring Every Journey in Duchenne and Becker: Advancing Therapies, Access, and Care For All
- DMD treatment Kymbee launches with support program for patients